The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The observations are procedural in nature
Expands robotics to 20+ specialities
Biocorp will receive an initial milestone payment this year
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Subscribe To Our Newsletter & Stay Updated
